- Home
- CATO vs DTIL Comparison
CATO vs DTIL Comparison
Compare CATO & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- DTIL
- Stock Information
- Founded
- CATO 1946
- DTIL 2006
- Country
- CATO United States
- DTIL United States
- Employees
- CATO N/A
- DTIL N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- DTIL Health Care
- Exchange
- CATO Nasdaq
- DTIL Nasdaq
- Market Cap
- CATO 59.2M
- DTIL 51.6M
- IPO Year
- CATO N/A
- DTIL 2019
- Fundamental
- Price
- CATO $2.85
- DTIL $4.13
- Analyst Decision
- CATO
- DTIL Strong Buy
- Analyst Count
- CATO 0
- DTIL 2
- Target Price
- CATO N/A
- DTIL $47.00
- AVG Volume (30 Days)
- CATO 41.5K
- DTIL 531.7K
- Earning Date
- CATO 08-21-2025
- DTIL 07-31-2025
- Dividend Yield
- CATO 6.06%
- DTIL N/A
- EPS Growth
- CATO N/A
- DTIL N/A
- EPS
- CATO N/A
- DTIL N/A
- Revenue
- CATO $642,949,000.00
- DTIL $51,141,000.00
- Revenue This Year
- CATO N/A
- DTIL N/A
- Revenue Next Year
- CATO N/A
- DTIL $30.20
- P/E Ratio
- CATO N/A
- DTIL N/A
- Revenue Growth
- CATO N/A
- DTIL N/A
- 52 Week Low
- CATO $2.19
- DTIL $3.61
- 52 Week High
- CATO $6.70
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- CATO 52.16
- DTIL 35.43
- Support Level
- CATO $2.71
- DTIL $4.02
- Resistance Level
- CATO $2.99
- DTIL $4.38
- Average True Range (ATR)
- CATO 0.21
- DTIL 0.34
- MACD
- CATO -0.02
- DTIL -0.08
- Stochastic Oscillator
- CATO 25.64
- DTIL 8.66
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.